Krishna Institute of Medical Sciences Secures Listing Approval from BSE and NSE for 1,98,67,549 QIP Equity Shares
Krishna Institute of Medical Sciences Ltd has received listing approvals from both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for the shares issued under a Qualified Institutional Placement (QIP). The shares were allotted to qualified institutional buyers.The approval concerns the listing of 1,98,67,549 equity shares, each with a face value of Rs. 2/- following the QIP.
Listing and Approval Details
Krishna Institute of Medical Sciences informed stakeholders about the successful procurement of necessary clearances from major stock exchanges for these securities. The company secured in-principle approval from the NSE regarding the listing of the shares against its application. Similarly, BSE granted listing approval for the aforementioned equity shares.The details of the issuance and listing are as follows:
| Parameter | Details |
|---|---|
| Company Name | Krishna Institute of Medical Sciences Ltd |
| Placement Type | Qualified Institutional Placement (QIP) |
| Total Shares Issued | 1,98,67,549 |
| Face Value per Share | Rs. 2/- |
| Approving Exchanges | BSE and NSE |
The approval granted by the National Stock Exchange of India Limited was subsequent to perusing the listing application and related documents submitted by the company. The NSE stated that the shares would be listed and admitted for trading upon receiving confirmation from depositories like NSDL or CDSL regarding credit into beneficiaries' accounts.
KIMS Stock Price Movement
Shares of Krishna Institute of Medical Sciences Limited shed 0.19% during live trading, reaching ₹804.6 as of 2:36 PM. This decline follows considerable volatility in the stock, which previously hit its 52-week high and traded over 294,000 shares so far today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.